We are live on ! Find out more
Squarepoint

Squarepoint Portfolio holdings

AUM $90.5B
1-Year Est. Return 33.95%
This Fund
S&P 500
This Quarter Est. Return
+17.08%
1 Year Est. Return
+33.95%
3 Year Est. Return
+77.62%
5 Year Est. Return
+56.06%
10 Year Est. Return
+196.47%
AUM
$13.4B
AUM Growth
+$5.98B
Cap. Flow
+$3.16B
Cap. Flow %
23.6%
Top 10 Hldgs %
24.57%
Holding
3,476
New
1,044
Increased
804
Reduced
979
Closed
616

Top Sells

Rank Stock Value
1
INTU icon
Intuit
INTU
+$51.4M
2
LOW icon
Lowe's Companies
LOW
+$45.3M
3
CVS icon
CVS Health
CVS
+$37.3M
4
LLY icon
Eli Lilly
LLY
+$32.7M
5
SO icon
Southern Company
SO
+$30.6M

Sector Composition

Rank Sector Weight
1 Miscellaneous 34.4%
2 Technology 14.71%
3 Consumer Discretionary 11.73%
4 Healthcare 8.95%
5 Financials 6.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KRUS icon
2126
Kura Sushi USA
KRUS
$419M
$334K ﹤0.01%
+17,152
New +$277K
NVRI icon
2127
Enviri
NVRI
$579M
$334K ﹤0.01%
18,556
+4,344
+31% +$69.8K
VBTX
2128
DELISTED
Veritex Holdings
VBTX
$334K ﹤0.01%
13,000
+174
+1% +$3.83K
XOM icon
2129
PUT
ExxonMobil
XOM
$671B
$334K ﹤0.01%
8,100
+1,700
+27% +$63.7K
DLTH icon
2130
Duluth Holdings
DLTH
$159M
$333K ﹤0.01%
31,542
+8,936
+40% +$122K
OYST
2131
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
$333K ﹤0.01%
+17,672
New +$381K
EOLS icon
2132
Evolus
EOLS
$529M
$332K ﹤0.01%
98,956
+88,845
+879% +$334K
HGV icon
2133
Hilton Grand Vacations
HGV
$2.89B
$331K ﹤0.01%
+10,551
New +$276K
MRLN
2134
DELISTED
Marlin Business Services Corp
MRLN
$331K ﹤0.01%
27,050
+7,916
+41% +$77.2K
AGRX
2135
DELISTED
Agile Therapeutics
AGRX
$330K ﹤0.01%
+57
New +$336K
FOX icon
2136
Fox Class B
FOX
$24.6B
$329K ﹤0.01%
+11,405
New +$316K
CUE icon
2137
Cue Biopharma
CUE
$275M
$328K ﹤0.01%
874
+209
+31% +$83.5K
IBP icon
2138
Installed Building Products
IBP
$5.29B
$328K ﹤0.01%
3,221
+644
+25% +$65.8K
FLGT icon
2139
Fulgent Genetics
FLGT
$601M
$327K ﹤0.01%
6,278
-7,426
-54% -$310K
WLY icon
2140
John Wiley & Sons Class A
WLY
$2.5B
$327K ﹤0.01%
7,167
-22,956
-76% -$831K
RCM
2141
DELISTED
R1 RCM Inc. Common Stock
RCM
$327K ﹤0.01%
13,605
-623
-4% -$12.4K
PBI icon
2142
Pitney Bowes
PBI
$2.37B
$326K ﹤0.01%
+52,884
New +$318K
TMO icon
2143
CALL
Thermo Fisher Scientific
TMO
$243B
$326K ﹤0.01%
700
TMO icon
2144
PUT
Thermo Fisher Scientific
TMO
$243B
$326K ﹤0.01%
700
AEL
2145
DELISTED
American Equity Investment Life Holding Company
AEL
$325K ﹤0.01%
+11,736
New +$324K
CLCT
2146
DELISTED
Collectors Universe
CLCT
$325K ﹤0.01%
4,311
-252
-6% -$17.1K
APAM icon
2147
Artisan Partners
APAM
$2.59B
$323K ﹤0.01%
6,408
-19,360
-75% -$880K
GIL icon
2148
Gildan
GIL
$8.57B
$323K ﹤0.01%
11,543
-5,136
-31% -$126K
HBNC icon
2149
Horizon Bancorp
HBNC
$1B
$323K ﹤0.01%
20,336
+5,248
+35% +$71.9K
MSEX icon
2150
Middlesex Water
MSEX
$1.06B
$323K ﹤0.01%
+4,461
New +$308K

Similar funds

Squarepoint's Q4 2020 Portfolio in Review

As of Q4 2020, Squarepoint held 3,476 positions worth $13.4B, up 81% from $7.42B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Squarepoint deployed $3.16B of net new capital in Q4 2020, opening 1,044 new positions and adding to 804 existing holdings. Its largest new stake was iShares Core S&P 500 ETF: 4,102,602 shares worth $1.54B.

By sector, the portfolio is most concentrated in Miscellaneous at 34% of assets, up from 10% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Intuit, an estimated $51.4M trimmed.

  • Squarepoint's largest Q4 2020 buy was iShares Core S&P 500 ETF: 4,102,602 shares worth $1.54B.
  • Squarepoint added most to State Street SPDR S&P 500 ETF Trust in Q4 2020, an estimated $437M increase.
  • Squarepoint's biggest Q4 2020 reduction was Intuit, cutting an estimated $51.4M.
  • Squarepoint fully exited iShares Biotechnology ETF in Q4 2020, selling an estimated $29.3M.
  • Squarepoint's ten largest holdings make up 25% of its $13.4B portfolio in Q4 2020.
  • Squarepoint opened 1,044 new positions and closed 616 in Q4 2020.
  • Squarepoint's portfolio value rose 81% quarter-over-quarter to $13.4B.

Based on Squarepoint's 13F filing for Q4 2020, filed 16 Feb 2021.